Aspire Biopharma Holdings, Inc. filed a Certificate of Amendment to change its name to Aspire-Lakewood Holdings, Inc., effective September 8, 2026, with no stockholder approval required and the trading symbol remaining ASBP. Concurrently, the Board authorized an expanded $10 million common stock repurchase program effective September 9, 2026, citing strong free cash flow generation from its acquisition of Dura Control Systems Corp (DCSC). DCSC contributed approximately $209.5 million in revenue and $22.3 million in Adjusted EBITDA for the full year 2025, supporting management's view that the share price does not reflect the company's financial strength. The repurchase program has no expiration date and may be suspended at any time. Aspire-Lakewood Holdings operates as a holding company with subsidiaries in automotive control systems and biopharmaceutical development.

Aspire Biopharma Holdings, Inc. announced a corporate name change to Aspire-Lakewood Holdings, Inc., effective upon filing a Certificate of Amendment with the Delaware Secretary of State. The company's Nasdaq ticker symbol remains ASBP. This rebranding reflects a strategic evolution following the acquisition of Dura Control Systems Corp., transitioning the entity into a holding company structure for its diversified operations. Aspire-Lakewood Holdings operates in the industrial and automotive sectors, primarily through its subsidiary Dura Control Systems Corp., which designs and manufactures engineered control systems for vehicle electrification and industrial applications.

On June 16, 2026, stockholders approved three proposals: the issuance of shares upon the exercise of warrants (including those exceeding 19.99% of outstanding common stock as of April 22, 2026) at an exercise price of $0.00001 per share, the adjustment of the number of shares issuable upon warrant exercise, and voluntary adjustments to the warrant exercise price. The company operates in the biopharmaceutical industry and develops therapeutic products.

Aspire Biopharma Holdings, Inc. entered into a purchase agreement with FireFish TopCo, LLC to acquire all equity interests in certain subsidiaries and all assets of other business entities. The transaction involves a base purchase price of $30,000,000 plus $800,000 for deferred revenue, adjusted for tax obligations and indebtedness. The acquisition targets automotive systems businesses, specifically driver control systems in the Czech Republic and the United States. Aspire Biopharma Holdings, Inc. operates in the automotive technology sector, focusing on electronic driver control and vehicle electrification and sustainability systems.